Novavax Inc vs Ross Stores, Inc. — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Ross Stores, Inc. trades at $235 (market cap $75.63B). The key difference: Ross Stores, Inc. is far larger — about 58.2× Novavax Inc's market cap, and Ross Stores, Inc. pays a 0.75% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | ROST | |
|---|---|---|
Market Cap | $1.30B | $75.63B |
Sector | Health | Consumer Cyclical |
52-Week High | $11.19 | $240.13 |
52-Week Low | $6.22 | $134.02 |
Enterprise Value | $800.50M | $76.23B |
Dividend Yield | — | 0.75% |
Trailing returns across standard periods
Latest headlines on both assets
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →